Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults

Adults with relapsed or refractory B-cell acute lymphoblastic leukemia have a dismal prognosis with a short median overall survival that can be measured in months. Because most patients will have chemotherapy-resistant disease, allogeneic hematopoietic stem cell transplantation remains the only pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kum Ja, Chow, Vivian, Weissman, Ashley, Tulpule, Sunil, Aldoss, Ibrahim, Akhtari, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003562/
https://www.ncbi.nlm.nih.gov/pubmed/27601914
http://dx.doi.org/10.2147/TCRM.S84261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003562/
https://www.ncbi.nlm.nih.gov/pubmed/27601914
http://dx.doi.org/10.2147/TCRM.S84261

Ejemplares similares